SCHEMBL1369573

SCHEMBL1369573

[c]1ccc(-c2ccc3cccc4c5cccc6cccc(c2c34)c65)cc1

nearest known ligand 0.47

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 5/20 0.47
HSD17B10 Q99714 5/20 0.47
HPGD P15428 4/20 0.47
CYP1A2 P05177 3/20 0.47
THRB P10828 1/20 0.47
ERBB2 P04626 1/20 0.39
FYN P06241 1/20 0.39
MAOA P21397 1/20 0.39
ACHE P22303 1/20 0.39
AHR P35869 1/20 0.39
TSHR P16473 4/20 0.34
CYP3A4 P08684 2/20 0.34
CYP1A1 P04798 1/20 0.34
CYP1B1 Q16678 1/20 0.34
L3MBTL1 Q9Y468 3/20 0.33
TDP1 Q9NUW8 1/20 0.33
MAPK1 P28482 2/20 0.32
CASP1 P29466 1/20 0.32
HIF1A Q16665 1/20 0.32
CDK4 P11802 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL29669708 0.87 ALDH1A1 (0.56) ALDH1A1HSD17B10HPGDCYP1A2THRB
SCHEMBL5139143 0.83 ALDH1A1 (0.58) ALDH1A1HSD17B10HPGDCYP1A2THRB
SCHEMBL1335879 0.81 ALDH1A1 (0.44) ALDH1A1HSD17B10HPGDCYP1A2THRB
SCHEMBL1371198 0.81 CYP1A2 (0.42) ALDH1A1HSD17B10HPGDCYP1A2THRB
SCHEMBL16321276 0.80 ALDH1A1 (0.64) ALDH1A1HSD17B10HPGDCYP1A2THRB
SCHEMBL29656951 0.80 ALDH1A1 (0.64) ALDH1A1HSD17B10HPGDCYP1A2THRB
SCHEMBL20774194 0.80 HSD17B10 (0.43) ALDH1A1HSD17B10HPGDCYP1A2THRB
SCHEMBL20774337 0.79 CYP1A2 (0.47) ALDH1A1HSD17B10HPGDCYP1A2THRB
SCHEMBL11553887 0.79 ALDH1A1 (0.47) ALDH1A1HSD17B10HPGDCYP1A2THRB
SCHEMBL27822527 0.79 CYP1A2 (0.47) ALDH1A1HSD17B10HPGDCYP1A2THRB

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 14 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-115916907-A Compound (I) 住友化学株式会社 2023-04-04 CN disclosed
CN-112812024-B Organic compound, application and organic electroluminescent device using organic compound 陕西莱特迈思光电材料有限公司 2022-03-29 CN disclosed
US-11251377-B2 Organic light emitting device LG CHEM, LTD. (KR) 2022-02-15 US disclosed
CN-106604923-B Organic electroluminescent compounds and organic electroluminescent device comprising the same 罗门哈斯电子材料韩国有限公司 2022-02-01 CN disclosed
US-11189800-B2 Heterocyclic compound and organic light emitting device comprising the same LG CHEM, LTD. (KR) 2021-11-30 US disclosed
CN-104793383-B Liquid crystal display device with a light guide plate 默克专利股份有限公司 2021-09-07 CN disclosed
CN-112812024-A Organic compound, application and organic electroluminescent device using organic compound 陕西莱特迈思光电材料有限公司 2021-05-18 CN disclosed
CN-108063188-B Organic light emitting element 株式会社LG化学 2020-08-11 CN disclosed
US-20200058877-A1 ORGANIC LIGHT EMITTING DEVICE LG CHEM, LTD. (KR) 2020-02-20 US disclosed
US-20190207120-A1 HETEROCYCLIC COMPOUND AND ORGANIC LIGHT EMITTING DEVICE COMPRISING THE SAME LG CHEM, LTD. (KR) 2019-07-04 US disclosed
EP-2361909-B1 1,3,5-TRIAZINE DERIVATIVE, PROCESS FOR PRODUCING SAME, AND ORGANIC ELECTROLUMINESCENT ELEMENT COMPRISING SAME TOSOH CORP (JP) 2014-09-10 EP disclosed
US-8674091-B2 1,3,5-triazine derivative, process for producing same, and organic electroluminescent element comprising same as constituent TOSOH CORPORATION (JP) 2014-03-18 US disclosed
US-20110288295-A1 1,3,5-TRIAZINE DERIVATIVE, PROCESS FOR PRODUCING SAME, AND ORGANIC ELECTROLUMINESCENT DEVICE COMPRISING SAME SAGAMI CHEMICAL RESEARCH INSTITUTE (JP) 2011-11-24 US disclosed
EP-2361909-A1 1,3,5-TRIAZINE DERIVATIVE, PROCESS FOR PRODUCING SAME, AND ORGANIC ELECTROLUMINESCENT ELEMENT COMPRISING SAME Tosoh Corporation (JP) 2011-08-31 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20190207120-A1 HETEROCYCLIC COMPOUND AND ORGANIC LIGHT EMITTING DEVICE COMPRISING THE SAME CRY1, CYBA, CYP1B1 ALDH1A1 33/4885HSD17B10 972/4885HPGD 521/4885
US-20110288295-A1 1,3,5-TRIAZINE DERIVATIVE, PROCESS FOR PRODUCING SAME, AND ORGANIC ELECTROLUMINESCENT DEVICE COMPRISING SAME VDAC1, MT-ND5, TRPC5 ALDH1A1 235/4885HSD17B10 1606/4885HPGD 2648/4885
US-11189800-B2 Heterocyclic compound and organic light emitting device comprising the same CRY1, CYBA, CYP1B1 ALDH1A1 33/4885HSD17B10 972/4885HPGD 521/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.